Roscovitine Inhibits STAT5 Activity and Induces Apoptosis in the Human Leukemia Virus Type 1-Transformed Cell Line MT-2

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8523-8530

  Mohapatra, Subhra ^b   Chu, Baoky ^b   Wei, Sheng ^b   Djeu, Julie ^b   Epling Burnette, P K ^b   Loughran, Thomas ^b   Jove, Richard ^b   Pledger, W Jackson ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3 INHIBITOR; CYCLIN DEPENDENT KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; ROSCOVITINE; STAT5 PROTEIN; VANADATE SODIUM; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TRANSFORMED; DNA-BINDING PROTEINS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MILK PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTEINS; PURINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 0347626096     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Yoshida, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol., 19: 475-496, 2001.
2. Uchiyama, T. Human T cell leukemia virus type 1 (HTLV-1) and human diseases. Annu. Rev. Immunol., 15: 15-37, 1997.
3. Bazarbachi, A., and Hermine, O. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res., 78: 79-92, 2001.
4. Ruben, S., Poteat, H., Tan, T. H., Kawakami, K., Roeder, R., Haseltine, W., and Rosen, C. A. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science (Wash. DC), 241: 89-92, 1988.
5. Leung, K., and Nabel, G. J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature (Lond.), 333: 776-778, 1988.
6. Ballard, D. W., Bohnlein, E., Lowenthal, J. W., Wano, Y., Franza, B. R., and Greene, W. C. HTLV-1 tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science (Wash. DC), 241: 1652-1655, 1988.
7. Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., and Lipp, J. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis. J. Exp. Med., 188: 211-216, 1998.
8. L expression by human T-cell leukemia virus type 1 Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax. J. Virol., 73: 7981-7987, 1999.
9. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash. DC), 281: 1680-1683, 1998.
10. Mori, N., Yamada, Y., Hata, T., Ikeda, S., Yamasaki, Y., Tomonaga, M., and Yamamoto, N. Expression of survivin in HTLV-1-infected T-cell lines and primary ATL cells. Biochem. Biophys. Res. Commun., 282: 1110-1113, 2001.
11. Brauweiler, A., Garrus, J. E., Reed, J. C., and Nyborg, J. K. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology, 231: 135-140, 1997.
12. Yang, Y. C., Hsu, T. Y., Lin, R. H., Su, I. J., Chen, J. Y., and Yang, C. S. Resistance to tumor necrosis factor-α-induced apoptosis in human T-lymphotropic virus type I-infected T cell lines. AIDS Res. Hum. Retroviruses, 18: 207-212, 2002.
13. Nawata, H., Maeda, Y., Sumimoto, Y., Miyatake, J., and Kanamaru, A. A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-κB signaling pathway. Leuk. Res., 25: 323-331, 2001.
14. Darwiche, N., El-Sabban, M., Bazzi, R., Nasr, R., Al-Hashimi, S., Hermine, O., de The, H., and Bazarbachi, A. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor α-positive human T-cell lymphotropic virus type-1-transformed cells. Hematol. J., 2: 127-135, 2001.
15. El-Sabban, M. E., Nasr, R., Dbaibo, G., Hermine, O., Abboushi, N., Quignon, F., Ameisen, J. C., Bex, F., de The, H., and Bazarbachi, A. Arsenic-interferon-α-triggered apoptosis in HTLV-1 transformed cells is associated with tax down-regulation and reversal of NF-κB activation. Blood. 96: 2849-2855, 2000.
16. Bazarbachi, A., El-Sabban, M. E., Nasr, R., Quignon, F., Awaraji, C., Kersual, J., Dianoux, L., Zermati, Y., Haidar, J. H., Hermine, O., and de The, H. Arsenic trioxide and interferon-α synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type 1-transformed cells. Blood. 93: 278-283, 1999.
17. Kawakami, A., Nakashima, T., Sakai, H., Urayama, S., Yamasaki, S., Hida, A., Tsuboi, M., Nakamura, H., Ida, H., Migita, K., Kawabe, Y., and Eguchi, K. Inhibition of caspase cascade by HTLV-1 tax through induction of NF-κB nuclear translocation. Blood, 94: 3847-3854, 1999.
18. Portis, T., Harding, J. C., and Ratner, L. The contribution of NF-κB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood, 98: 1200-1208, 2001.
19. Mori, N., Yamada, Y., Ikeda, S., Yamasaki, Y., Tsukasaki, K., Tanaka, Y., Tomonaga, M., Yamamoto, N., and Fujii, M. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-1-infected T-cell lines and primary adult T-cell leukemia cells. Blood, 100: 1828-1834, 2002.
20. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Wash. DC), 264: 1415-1421, 1994.
21. Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O'Shea, J. J., and Nerenberg, M. I. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Investig., 96: 1548-1555, 1995.
22. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., and Leonard, W. J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science (Wash. DC), 269: 79-81, 1995.
23. Mulloy, J. C., Migone, T. S., Ross, T. M., Ton, N., Green, P. L., Leonard, W. J., and Franchini, G. Human and simian T-cell leukemia viruses type 2 (HTLV-2 and STLV-2(pan-p)) transform T cells independently of Jak/STAT activation. J. Virol., 72: 4408-4412, 1998.
24. Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T. S., Patel, B. K., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., Leonard, W. J., Waldmann, T., and Franchini, G. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl. Acad. Sci. USA. 94: 13897-13902, 1997.
25. +, IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. Leuk. Res., 23: 373-384, 1999.
26. L gene expression by STAT5 in a bone marrow derived cell line. Oncogene, 18: 4191-4199, 1999.
27. L. J. Exp. Med., 191: 977-984, 2000.
28. Sillaber, C., Gesbert, F., Frank, D. A., Sattler, M., and Griffin, J. D. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood, 95: 2118-2125, 2000.
29. Kieslinger, M., Woldman, I., Moriggl, R., Hofmann, J., Marine, J. C., Ihle, J. N., Beug, H., and Decker, T. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev., 14: 232-244, 2000.
30. L induction. Cell, 98: 181-191, 1999.
31. Lin, T. S., Mahajan, S., and Frank, D. A. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene, 19: 2496-2504, 2000.
32. Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J. G., and Moulinoux, J. P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem., 243: 527-536, 1997.
33. Pines, J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J., 308: 697-711, 1995.
34. Somerville, L., and Cory, J. G. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res., 20: 3347-3355, 2001.
35. Mgbonyebi, O. P., Russo, J., and Russo, I. H. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res., 59: 1903-1910, 1999.
36. David-Pfeuty, T. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells. Oncogene, 18: 7409-7422, 1999.
37. Iseki, H., Ko, T. C., Xue, X. Y., Seapan, A., Hellmich, M. R., and Townsend, C. M., Jr. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. Surgery (St Louis), 122: 187-194, discussion 194-185, 1997.
38. Iseki, H., Ko, T. C., Xue, X. Y., Seapan, A., and Townsend, C. M., Jr. A novel strategy for inhibiting growth of human pancreatic cancer cells by blocking cyclin-dependent kinase activity. J. Gastrointest. Surg., 2: 36-43, 1998.
39. Ncho, M., and Brahmi, Z. Evidence that Fas-induced apoptosis leads to S phase arrest. Hum. Immunol. 62: 310-319, 2001.
40. Mihara, M., Shintani, S., Kiyota, A., Matsumura, T., and Wong, D. T. Cyclin-dependent kinase inhibitor (roscovitine) suppresses growth and induces apoptosis by regulating Bcl-X in head and neck squamous cell carcinoma cells. Int. J. Oncol., 21: 95-101, 2002.
41. Edamatsu, H., Gau, C. L., Nemoto, T., Guo, L., and Tamanoi, F. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines. Oncogene, 19: 3059-3068, 2000.
42. Atienza, C., Jr., Elliott, M. J., Dong, Y. B., Yang, H. L., Stilwell, A., Liu, T. J., and McMasters, K. M. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors. Int. J. Mol. Med., 6: 55-63, 2000.
43. Elliott, M. J., Fanner, M. R., Atienza, C., Jr., Stilwell, A., Dong, Y. B., Yang, H. L., Wong, S. L., and McMasters, K. M. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells. Tumour Biol., 23: 76-86, 2002.
44. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol., 16: 4327-4336, 1996.
45. Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Hong-Geller, E., Wei, S., and Djeu, J. Y. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol., 1: 419-425, 2000.
46. Coats, S. R., Love, H. D., and Pledger, W. J. Platelet-derived growth factor (PDGF)-AB-mediated phosphorylation of PDGF β receptors. Biochem. J., 297: 379-384, 1994.
47. Lin, J. X., and Leonard, W. J. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene, 19: 2566-2576, 2000.
48. Chang, H. Y., and Yang, X. Proteases for cell suicide: functions and regulation of caspases. Microbiol. Mol. Biol. Rev., 64: 821-846, 2000.
49. Huang, M., Dorsey, J., Epling-Burnette, P. K., Nimmanapalli, R., Landowski, T., Mora, L., Niu, G., Sinibaldi, D., Bai, F., Kraker, A., Yu, H., Moscinski, L., Wei, S., Djeu, J., Dalton, W., Bhalla, K., Loughran, T., Wu, J., and Jove, R. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene, 21: 8804-8816, 2002.
50. Siebenlist, U., Franzoso, G., and Brown, K. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol., 10: 405-455, 1994.
51. Heldin, C. H., and Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev., 79: 1283-1316, 1999.
52. Goustin, A. S., Galanopoulos, T., Kalyanaraman, V. S., and Pantazis, P. Coexpression of the genes for platelet-derived growth factor and its receptor in human T-cell lines infected with HTLV-1. Growth Factors, 2: 189-195, 1990.
53. Salahuddin, S. Z., Markham, P. D., Lindner, S. G., Gootenberg, J., Popovic, M., Hemmi, H., Sarin, P. S., and Gallo, R. C. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science (Wash. DC), 223: 703-707, 1984.
54. Ratner, L., Josephs, S. F., Jarrett, R., Reitz, M. S., Jr., and Wong-Staal, F. Nucleotide sequence of transforming human c-sis cDNA clones with homology to platelet-derived growth factor. Nucleic Acids Res., 13: 5007-5018, 1985.
55. Pantazis, P., Sariban, E., Bohan, C. A., Antoniades, H. N., and Kalyanaraman, V. S. Synthesis of PDGF by cultured human T cells transformed with HTLV-1 and II. Oncogene, 1: 285-289, 1987.
56. Hoover, R. R., Gerlach, M. J., Koh, E. Y., and Daley, G. Q. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells. Oncogene, 20: 5826-5835, 2001.
57. Coffer, P. J., Koenderman, L., and de Groot, R. P. The role of STATs in myeloid differentiation and leukemia. Oncogene, 19: 2511-2522, 2000.
58. Nieborowska-Skorska, M., Wasik, M. A., Slupianek, A., Salomoni, P., Kitamura, T., Calabretta, B., and Skorski, T. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J. Exp. Med., 189: 1229-1242, 1999.
59. Kirken, R. A., Erwin, R. A., Wang, L., Wang, Y., Rui, H., and Farrar, W. L. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type I-transformed human T cells. J. Immunol., 165: 5097-5104, 2000.
60. Paukku, K., Valgeirsdottir, S., Saharinen, P., Bergman, M., Heldin, C. H., and Silvennoinen, O. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF β-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem. J., 345: 759-766, 2000.
61. Beisenherz-Huss, C., Mundt, M., Herrala, A., Vihko, P., Schubert, A., and Groner, B. Specific DNA binding and transactivation potential of recombinant, purified Stat5. Mol. Cell. Endocrinol., 183: 101-112, 2001.
62. Cirri, P., Chiarugi, P., Marra, F., Raugei, G., Camici, G., Manao, G., and Ramponi, G. c-Src activates both Stat1 and Stat3 in PDGF-stimulated NIH 3T3 cells. Biochem. Biophys. Res. Commun., 239: 493-497, 1997.
63. Wang, Y. Z., Wharton, W., Garcia, R., Kraker, A., Jove, R., and Pledger, W. J. Activation of Stat3 preassembled with platelet-derived growth factor β receptors requires Src kinase activity. Oncogene, 19: 2075-2085, 2000.
64. Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C. J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., Demetri, G. D., Fletcher, C. D., and Fletcher, J. A. PDGFRA activating mutations in gastrointestinal stromal tumors. Science (Wash. DC), 299: 708-710, 2003.
65. Chiarugi, P., Cirri, P., Marra, F., Raugei, G., Fiaschi, T., Camici, G., Manao, G., Romanelli, R. G., and Ramponi, G. The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling. J. Biol. Chem., 273: 6776-6785, 1998.
66. Yu, Z., Su, L., Hoglinger, O., Jaramillo, M. L., Banville, D., and Shen, S. H. SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem., 273: 3687-3694, 1998.
67. Migone, T. S., Cacalano, N. A., Taylor, N., Yi, T., Waldmann, T. A., and Johnston, J. A. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci. USA, 95: 3845-3850, 1998.
68. Mohapatra, S., and Pledger, W. J. Interdependence of cdk2 activation and IL-2Rα accumulation in T cells. J. Biol. Chem., 276: 21984-21989, 2001.
69. Zhang, H. G., Huang, N., Liu, D., Bilbao, L., Zhang, X., Yang, P., Zhou, T., Curiel, D. T., and Mountz, J. D. Gene therapy that inhibits nuclear translocation of nuclear factor κB results in tumor necrosis factor α-induced apoptosis of human synovial fibroblasts. Arthritis Rheum., 43: 1094-1105, 2000.
70. Lin, H., Chen, C., and Chen, B. D. Resistance of bone marrow-derived macrophages to apoptosis is associated with the expression of X-linked inhibitor of apoptosis protein in primary cultures of bone marrow cells. Biochem. J., 353: 299-306, 2001.
71. Xiao, C. W., Ash, K., and Tsang, B. K. Nuclear factor-κB-mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor α-induced apoptosis. Endocrinology, 142: 557-563, 2001.
72. Lin, H., Chen, C., Li, X., and Chen, B. D. Activation of the MEK/MAPK pathway is involved in bryoslatin 1-induced monocytic differentiation and up-regulation of X-linked inhibitor of apoptosis protein. Exp. Cell Res., 272: 192-198, 2002.